SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-041970
Filing Date
2022-02-14
Accepted
2022-02-14 16:43:07
Documents
2
Group Members
CHART WESTCOTTNEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d287525dsc13ga.htm SC 13G/A 79525
2 EX-99.1 d287525dex991.htm EX-99.1 4765
  Complete submission text file 0001193125-22-041970.txt   85976
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 22633532
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A